ESMO Magnitude of Clinical Benefit Scale assists oncology clinicians in evaluating anti-cancer medicines

Related posts:

1. Life-prolonging protein could inhibit ageing diseases Researchers have found a molecule that plays a key link between dietary restriction and longevity in mammals. This discovery may lead to the development of new therapies to inhibit age-related diseases....
2. New survey: Percentage of Texans without health insurance drops dramatically The percentage of Texans without health insurance dropped 31 percent since enrollment began in the Affordable Care Act's (ACA) Health Insurance Marketplace, according to a new report released by the......
3. Modifying stem cells shows initial promise in battle against muscular dystrophy A group of University of Florida Health researchers has found a way to reverse the effects of one type of muscular dystrophy by editing the genome of nervous system stem cells....
4. Blood pressure medications can lead to increased risk of stroke The importance of preventing hypertension is reinforced by a study showing anti-hypertension medicines can increase stroke risk by 248 percent, according to new research....
5. Altered pain processing in patients with cognitive impairment People with dementia and other forms of cognitive impairment (CI) have altered responses to pain, with many conditions associated with increased pain sensitivity, concludes a new research review....